James Bearden to Administration, Cutaneous
This is a "connection" page, showing publications James Bearden has written about Administration, Cutaneous.
Connection Strength
0.040
-
A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA. Support Care Cancer. 2011 Jun; 19(6):833-41.
Score: 0.022
-
Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3. J Natl Cancer Inst. 2007 May 02; 99(9):672-9.
Score: 0.018